| Activation of microbial secondary metabolic pathways: Avenues and challenges |
25 |
| CRISPR-Cas9/Cas12a biotechnology and application in bacteria |
17 |
| A living foundry for Synthetic Biological Materials: A synthetic biology roadmap to new advanced materials |
15 |
| Systematically investigating the key features of the DNase deactivated Cpf1 for tunable transcription regulation in prokaryotic cells |
13 |
| Simple glycolipids of microbes: Chemistry, biological activity and metabolic engineering |
12 |
| Therapeutic applications of genetic code expansion |
11 |
| Engineering and modification of microbial chassis for systems and synthetic biology |
11 |
| Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate |
10 |
| Methods to reduce variability in E. Coli-based cell-free protein expression experiments |
8 |
| Cell-free synthetic biology for in vitro biosynthesis of pharmaceutical natural products |
8 |
| Efficient editing DNA regions with high sequence identity in actinomycetal genomes by a CRISPR-Cas9 system |
8 |
| Simultaneously down-regulation of multiplex branch pathways using CRISPRi and fermentation optimization for enhancing beta-amyrin production in Saccharomyces cerevisiae |
8 |
| Improved production of docosahexaenoic acid in batch fermentation by newly-isolated strains of Schizochytrium sp. and Thraustochytriidae sp. through bioprocess optimization |
7 |
| Cell-free protein synthesis enabled rapid prototyping for metabolic engineering and synthetic biology |
7 |
| Regulation of antibiotic biosynthesis in actinomycetes: Perspectives and challenges |
7 |
| Conversion of D-glucose to L-lactate via pyruvate by an optimized cell-free enzymatic biosystem containing minimized reactions |
7 |
| An in vitro synthetic biology platform for emerging industrial biomanufacturing: Bottom-up pathway design |
6 |
| Rational and semi-rational engineering of cytochrome P450s for biotechnological applications |
6 |
| Nocardiopsistins A-C: New angucyclines with anti-MRSA activity isolated from a marine sponge-derived Nocardiopsis sp. HB-J378 |
6 |
| Genomic and transcriptional changes in response to pinene tolerance and overproduction in evolved Escherichia coli |
6 |
| The phage T4 DNA ligase mediates bacterial chromosome DSBs repair as single component non-homologous end joining |
6 |
| Cell-free synthesis of stable isotope-labeled internal standards for targeted quantitative proteomics |
5 |
| Metabolic engineering of Corynebacterium glutamicum S9114 based on whole-genome sequencing for efficient N-acetylglucosamine synthesis |
5 |
| Resistance mechanisms and reprogramming of microorganisms for efficient biorefinery under multiple environmental stresses |
5 |
| Resolution of deep divergence of club fungi (phylum Basidiomycota) |
5 |
| Blossom of CRISPR technologies and applications in disease treatment |
5 |
| Comparative functional genomics of the acarbose producers reveals potential targets for metabolic engineering |
4 |
| Enhancement of precursor amino acid supplies for improving bacitracin production by activation of branched chain amino acid transporter BrnQ and deletion of its regulator gene lrp in Bacillus licheniformis |
4 |
| Miniaturisation of high-throughput plasmid DNA library preparation for next-generation sequencing using multifactorial optimisation |
4 |
| Simplified methodology for a modular and genetically expanded protein synthesis in cell-free systems |
4 |
| Phosphate limitation increases coenzyme Q(10) production in industrial Rhodobacter sphaeroides HY01 |
4 |
| Efficient biosynthesis of 2-keto-D-gluconic acid by fed-batch culture of metabolically engineered Gluconobacter japonicus |
4 |
| Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
3 |
| Synergistic drug combinations prediction by integrating pharmacological data |
3 |
| Streptomyces avermitilis industrial strain as cell factory for Ivermectin B1a production |
3 |
| Crystal structure of the condensation domain from lovastatin polyketide synthase |
3 |
| SCO a TetR family regulator, is responsible for osmotic stress in Streptomyces coelicolor |
3 |
| The functional differentiation of the post-PKS tailoring oxygenases contributed to the chemical diversities of atypical angucyclines |
3 |
| Substrate specificity of the cypemycin decarboxylase CypD |
2 |
| A genetically engineered Escherichia coli that senses and degrades tetracycline antibiotic residue |
2 |
| Synthetic immunology: T-cell engineering and adoptive immunotherapy |
2 |
| Engineering metabolic pathways in Amycolatopsis japonicum for the optimization of the precursor supply for heterologous brasilicardin congeners production |
2 |
| Expanding beyond canonical metabolism: Interfacing alternative elements, synthetic biology, and metabolic engineering |
2 |
| Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228 |
2 |
| Benchmarking two Saccharomyces cerevisiae laboratory strains for growth and transcriptional response to methanol |
2 |
| Design and synthesis of synthetic UP elements for modulation of gene expression in Escherichia coli |
2 |
| New KAT6 inhibitors induce senescence and arrest cancer growth |
1 |
| A LuxR family transcriptional regulator AniF promotes the production of anisomycin and its derivatives in Streptomyces hygrospinosus var. beijingensis |
1 |
| Brocaeloid D, a novel compound isolated from a wheat pathogenic fungus, Microdochium majus 99049 |
1 |
| Engineering strong and stress-responsive promoters in Bacillus subtilis by interlocking sigma factor binding motifs |
1 |
